Does FERRIC DERISOMALTOSE Cause Hyperphosphataemia? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Hyperphosphataemia have been filed in association with FERRIC DERISOMALTOSE (Monoferric). This represents 1.2% of all adverse event reports for FERRIC DERISOMALTOSE.
12
Reports of Hyperphosphataemia with FERRIC DERISOMALTOSE
1.2%
of all FERRIC DERISOMALTOSE reports
12
Deaths
12
Hospitalizations
How Dangerous Is Hyperphosphataemia From FERRIC DERISOMALTOSE?
Of the 12 reports, 12 (100.0%) resulted in death, 12 (100.0%) required hospitalization, and 11 (91.7%) were considered life-threatening.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FERRIC DERISOMALTOSE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does FERRIC DERISOMALTOSE Cause?
Dyspnoea (223)
Flushing (126)
Chest discomfort (117)
Nausea (114)
Back pain (103)
Infusion related reaction (86)
Dizziness (75)
Pruritus (73)
Vomiting (63)
Chest pain (61)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)
Which FERRIC DERISOMALTOSE Alternatives Have Lower Hyperphosphataemia Risk?
FERRIC DERISOMALTOSE vs FERRIC HYDROXIDE
FERRIC DERISOMALTOSE vs FERRIC MALTOL
FERRIC DERISOMALTOSE vs FERRIC OXYHYDROXIDE
FERRIC DERISOMALTOSE vs FERROUS
FERRIC DERISOMALTOSE vs FERROUS ANHYDROUS